---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-112194"
form_type: "8-K"
ticker: null
cik: "0001929589"
company_name: "MariaDB plc"
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T07:22:46.767525+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MariaDB gets NYSE delisting notice for lack of independent directors and audit committee

## Summary
- NYSE notice Oct 23, 2023: MariaDB lacks majority independent directors and three independent audit committee members; cure by Oct 30 or BC indicator Nov 1.
- Prior NYSE non-compliance: avg market cap <$50M and equity <$50M (Sept), stock price <$1.00 (June); cure periods ongoing.
- Company intends to file plan for market cap deficiency within 45 days; stock price cure within six-month period.
- 2024 annual meeting set for March 12, 2024; shareholder proposals due Nov 10, 2023; director nominations due Dec 13–Jan 12, 2024.

## SEC filing metadata
- accession: 0001104659-23-112194
- form_type: 8-K
- cik: 0001929589
- company_name: MariaDB plc
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1929589/000110465923112194/0001104659-23-112194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1929589/000110465923112194/tm2329231d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-112194
- JSON: https://secwatch.observer/filing/0001104659-23-112194.json
- Plain text: https://secwatch.observer/filing/0001104659-23-112194.txt

## Key facts
- Listing & Compliance Notices
  MariaDB plc received a nyse deficiency notice notice regarding market value (rules 802.01B).
  - Exchange: nyse
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 802.01B
  source text: ng standards. The Company is currently considering its next steps regarding compliance. As previously disclosed in the Company’s Current Report on Form 8-K filed on September 22, 2023, the Company received written notice from the NYSE on September 19, 2023 that it was not in compliance with Section 802.01B of the Manual because the average global market capitalization of the Company over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company’s last reported stockholders’ equity was less than $50 million. In connection with the September notice, the Com
  evidence_url: https://www.sec.gov/Archives/edgar/data/1929589/000110465923112194/0001104659-23-112194-index.htm
- Listing & Compliance Notices
  MariaDB plc received a nyse deficiency notice notice regarding audit committee (rules 303A.01, 303A.07(a)).
  - Exchange: nyse
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 303A.01, 303A.07(a)
  source text: October 23, 2023, the Company received written notice (the “ Notice ”) from the NYSE that the Company was not in compliance with the corporate governance listing standards set forth in Section 303A.01 and 303A.07(a) of the Manual because the Company does not have a majority of independent directors and does not have three independent members on the audit committee. If the Company does not cure the deficiencies by October 30, 2023, a below compliance (“BC”) indicator will be disseminated over the consolidated tape and displayed on the Company’s NYSE profile starting November 1, 2023. Such indic
  evidence_url: https://www.sec.gov/Archives/edgar/data/1929589/000110465923112194/0001104659-23-112194-index.htm
- Listing & Compliance Notices
  MariaDB plc received a nyse deficiency notice notice regarding market value (rules 802.01C).
  - Exchange: nyse
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 802.01C
  source text: June 28, 2023 that it was not in compliance with Section 802.01C of the Manual because the average closing price of the Company’s ordinary shares was less than $1.00 over a consecutive 30 trading-day period. In connection with the June notice, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard with respect to the deficiency under Section 802.01C. The Company is currently within the six-month cure period for this deficiency following receipt of the June notice.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1929589/000110465923112194/0001104659-23-112194-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.